up by J&J and 68 have had to undergo revision surgeries to replace the faulty implant, according to data given by Maharashtra Food and Drug Administration.
DePuy said the company “is committed to addressing reasonable and customary costs of testing and treatment for reasons related to the recall, including revision surgery if necessary and advised by surgeons. DePuy will also pay for reasonable expenses related to receiving care, such as lost wages and travel costs.”
Last month, J&J agreed to pay compensation of $2.5 billion to settle consumer lawsuits filed by around 8,000 US citizens who sued the company after being fit with faulty hip implants.
In India, however, while the Maharashtra FDA has initiated an investigation after getting complaints from several patients seeking help to get compensation for similar faulty hip implants, there is only one case against the company in a consumer court. Lawyers are also skeptical over the amount of compensation that an Indian patient can expect. “It would be only in few lakhs that too after many years of fighting in the consumer courts,” said a senior High Court lawyer.